Spectrum Pharmaceuticals, Inc. (SPPI): Price and Financial Metrics

Spectrum Pharmaceuticals, Inc. (SPPI): $1.03

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

C

Stability

F

Sentiment

Quality

D

Add SPPI to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#156 of 383

in industry

SPPI Price/Volume Stats

Current price $1.03 52-week high $1.57
Prev. close $1.03 52-week low $0.32
Day low $0.97 Volume 5,931,300
Day high $1.06 Avg. volume 1,927,028
50-day MA $1.03 Dividend yield N/A
200-day MA $0.75 Market Cap 211.40M

SPPI Stock Price Chart Interactive Chart >


Spectrum Pharmaceuticals, Inc. (SPPI) Company Bio


Spectrum Pharmaceuticals is a leading biotechnology company focused on acquiring, developing, and commercializing drug products, with a primary focus in hematology and oncology. The company was founded in 1987 and is based in Henderson, Nevada.


SPPI Latest News Stream


Event/Time News Detail
Loading, please wait...

SPPI Latest Social Stream


Loading social stream, please wait...

View Full SPPI Social Stream

Latest SPPI News From Around the Web

Below are the latest news stories about SPECTRUM PHARMACEUTICALS INC that investors may wish to consider to help them evaluate SPPI as an investment opportunity.

Assertio Holdings, Inc. Closes Spectrum Pharmaceuticals Transaction

Combination of Assertio’s Omni-Channel Digital Sales Capabilities and ROLVEDON In-Person Commercial Team to Enhance Market Access and Growth Across All Products Transaction Expected to be Significantly Accretive to Assertio in 2024 LAKE FOREST, Ill., July 31, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that it has closed the proposed acquisition of S

Yahoo | July 31, 2023

Assertio Holdings, Inc. Announces Favorable Vote on Proposed Acquisition of Spectrum Pharmaceuticals

Stockholders From Both Assertio and Spectrum Have Overwhelmingly Voted in Support of the Transaction Transaction Expected to be Significantly Accretive to Assertio in 2024 LAKE FOREST, Ill. and BOSTON, July 27, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that its stockholders and the stockholders of Spectrum Pharmaceuticals, Inc. (“Spectrum”) (Nasdaq

Yahoo | July 27, 2023

Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote "FOR" Proposed Transaction with Assertio Holdings, Inc.

BOSTON, July 20, 2023--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) ("Spectrum" or the "Company") announced today that the leading independent proxy advisory firms, Institutional Shareholder Services, Inc. ("ISS") and Glass Lewis & Co. ("Glass Lewis"), have each recommended that Spectrum stockholders vote "FOR" the proposal to adopt the Agreement and Plan of Merger ("Merger Agreement", and such proposal, the "Merger Proposal") at the upcoming special meeting of stockholders (the "Special Meet

Yahoo | July 20, 2023

10 Special Situation Penny Stocks With Near Term Catalysts

In this piece, we will take a look at ten special situation penny stocks to consider. If you want to skip our analysis of the stock market and the economy, head on over to 5 Special Situation Penny Stocks to Consider. For the stock market these days, it’s nothing but cheers. June has proven to […]

Yahoo | June 27, 2023

Spectrum Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

BOSTON, May 17, 2023--Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) ("Spectrum" or the "Company"), a biopharmaceutical Company focused on novel and targeted oncology announced today that on May 16, 2023, the Company received a written notification from the Listing Qualifications Staff (the "Staff") of the Nasdaq Stock Market LLC (Nasdaq) that the Company has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2).

Yahoo | May 17, 2023

Read More 'SPPI' Stories Here

SPPI Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year 3.00%
3-year -67.81%
5-year -90.42%
YTD N/A
2023 0.00%
2022 -70.98%
2021 -62.76%
2020 -6.32%
2019 -58.40%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!